How Sterility Assurance Level (SAL) is Achieved
Sterility Assurance Level (SAL) is a fundamental concept in radiation sterilisation. It provides a quantitative expression of the probability of a viable microorganism being present on a product after sterilisation. Achieving the required SAL is not simply a matter of applying a particular radiation dose; it is the outcome of a controlled and validated sterilisation process.
What Does SAL 10-6 Mean?
A Sterility Assurance Level of 10-6 represents a theoretical probability of not more than one viable microorganism being present on a sterilised product following the sterilisation process, under the conditions defined by the applicable sterilisation process and validation framework.
It is important to understand that SAL is a probability-based concept. It does not mean that every individual sterilised unit is microbiologically tested and proven to contain absolutely no viable microorganisms.
How Is the Required SAL Achieved?
For radiation sterilisation, achieving the required SAL involves a chain of controlled activities rather than a single processing step. The process begins with understanding the microbiological characteristics of the product and progresses through dose establishment, dose mapping, dosimetry, validation and routine process control.
Understanding
Dose Establishment
Mapping
Validation
Control
1. Understanding the Initial Bioburden
Before establishing a sterilisation process, the manufacturer needs to understand the microbial population associated with the product. This microbial population, commonly referred to as bioburden, provides an important input into sterilisation dose establishment.
Bioburden is influenced by factors such as product materials, manufacturing environment, handling, packaging and the overall manufacturing process. Consequently, understanding the product's microbiological profile is an important foundation for developing an appropriate sterilisation process.
2. Establishing the Sterilisation Dose
Once the microbiological characteristics of the product are understood, an appropriate sterilisation dose can be established using a method consistent with the applicable radiation sterilisation framework.
The purpose of dose establishment is to provide objective evidence that the selected sterilisation dose is capable of achieving the required level of microbiological assurance for the product or product family.
Product
Material composition, configuration, packaging and product family characteristics.
Bioburden
The nature and level of microbial contamination associated with the product.
Selected Dose
A substantiated radiation dose appropriate for the defined sterilisation objective.
3. Understanding Dose Distribution
Establishing a sterilisation dose does not mean that every point within a product or irradiation load receives exactly the same absorbed dose.
Dose mapping is used to characterize the distribution and variability of radiation dose within the product or defined irradiation load. It helps identify comparatively lower and higher dose locations and provides evidence for understanding how the irradiation process interacts with the product configuration.
4. Measuring and Controlling Absorbed Dose
Dosimetry provides the measurement system used to determine absorbed radiation dose. During process development and validation, dosimeters are positioned at relevant locations to characterize dose delivery and establish the relationship between the irradiation process and the dose received by the product.
This distinction is important: dose mapping describes the distribution of dose, while dosimetry provides the measurements used to characterize that distribution.
Where?
Identifies how absorbed dose is distributed across relevant locations in the product or load.
How Much?
Provides measured absorbed-dose information at defined measurement locations.
Is It Controlled?
Establishes documented evidence that the defined process can consistently meet its requirements.
5. Validation Provides the Evidence
Validation brings the different elements together. The objective is to demonstrate that the defined radiation sterilisation process can consistently deliver the required microbiological effect while remaining suitable for the product.
For medical devices, this involves consideration of the product, packaging, bioburden, sterilisation dose, dose distribution and relevant process controls. The resulting documentation forms part of the objective evidence supporting the sterilisation process.
6. Maintaining SAL During Routine Processing
Achieving SAL during validation is only one part of the overall sterilisation strategy. Once a process has been established and validated, routine processing must remain within the defined and controlled conditions.
Routine control therefore relies on appropriate process parameters, dose measurement and monitoring, defined product and load configurations, and procedures for assessing relevant changes.
Changes to product design, materials or configuration may affect the established sterilisation process.
Packaging materials and configuration can influence radiation dose distribution and product compatibility.
Changes in how product is arranged within the irradiation load can influence dose distribution.
Routine dosimetry and process controls provide evidence that processing remains within established requirements.
Is SAL the Same as Sterility Testing?
No. Sterility Assurance Level and sterility testing address different aspects of the sterilisation process.
SAL is a probability-based measure of assurance associated with a validated sterilisation process. Sterility testing, by comparison, is a microbiological test performed on selected samples. A sterility test provides information about the tested samples; it does not by itself demonstrate that an entire production population has achieved a particular SAL.
Process-Based Assurance
SAL expresses the probability of a viable microorganism being present following a defined and validated sterilisation process.
Sample-Based Test
Sterility testing examines selected samples under defined test conditions and is not a substitute for sterilisation process validation.
Why SAL Does Not Mean “Zero Microorganisms”
One of the most common misconceptions about sterilisation is that achieving SAL 10-6 means proving that every sterilised unit contains absolutely zero viable microorganisms.
That is not what SAL means. SAL is a statistical and probabilistic expression of the effectiveness of a sterilisation process. The assurance level is established through a scientifically justified process rather than through destructive testing of every finished unit.
SAL is demonstrated through process understanding, microbiological evidence, dose establishment, validation and routine control — not by testing every individual product for sterility.
The Relationship Between Bioburden, Dose and SAL
These three concepts are closely connected within radiation sterilisation, but they represent different elements of the overall process.
Bioburden
Establishment
Processing
SAL
The initial microbial population is an important input into the dose establishment process. The selected sterilisation dose must then be supported by appropriate microbiological and process evidence. Dose distribution and absorbed dose are subsequently evaluated through appropriate dosimetry and process validation.
What Can Affect Sterility Assurance?
Maintaining a validated sterilisation process requires control of the factors that can influence microbiological effectiveness or delivered dose. Depending on the product and process, relevant considerations can include:
- Product configuration and changes in product design or materials
- Packaging configuration and material characteristics
- Bioburden characteristics associated with the product
- Loading configuration and product arrangement during irradiation
- Absorbed dose distribution throughout the defined irradiation configuration
- Routine process monitoring and adherence to validated processing conditions
How ISO 11137 Supports the SAL Framework
The ISO 11137 series provides the principal framework for radiation sterilisation of healthcare products, including requirements and guidance related to process development, validation, dosimetry and routine control.
The standards should therefore be viewed as an integrated framework rather than isolated technical documents. Dose establishment, dose mapping, dosimetry, validation and routine control each contribute to demonstrating and maintaining the required sterilisation outcome.
From Dose to Sterility Assurance
From a processing perspective, achieving the required SAL is fundamentally about establishing a scientifically justified connection between the product's microbiological characteristics, the selected sterilisation dose and the physical delivery of radiation to the product.
This is why dose establishment cannot be considered independently from dose mapping, dosimetry and validation. Each activity addresses a different part of the evidence required to demonstrate that the sterilisation process is appropriate for the defined product and configuration.
For manufacturers evaluating gamma sterilisation, the objective should not simply be to identify a nominal dose. The objective is to establish a controlled, validated and repeatable process capable of delivering the required microbiological assurance while maintaining product quality and functionality.
When Should the Sterilisation Process Be Revisited?
A validated sterilisation process should not be treated as permanently independent of product or manufacturing changes. Changes that could affect the established process may require technical evaluation to determine whether additional qualification, verification or validation activities are appropriate.
- Significant changes to product design or materials
- Changes to packaging materials or configuration
- Changes in product family or manufacturing conditions
- Changes to the irradiation load configuration
- Changes that could affect bioburden or microbiological characteristics
Conclusion
Achieving a Sterility Assurance Level is not simply a matter of exposing a medical device to radiation. It is the result of a structured sterilisation process supported by microbiological understanding, dose establishment, dose mapping, dosimetry, validation and routine process control.
For radiation sterilisation, SAL provides a quantitative expression of the assurance associated with the validated process. The strength of that assurance depends on how effectively the entire process is understood, established, validated and maintained.
Evaluating Gamma Sterilisation for a Medical Device?
Discuss your product configuration, sterilisation requirements and validation considerations with the VAPL technical team.
DISCUSS YOUR REQUIREMENT